<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR43">
 <label>43.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Oldenburg</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Mahlangu</surname>
    <given-names>JN</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Schmitt</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Callaghan</surname>
    <given-names>MU</given-names>
   </name>
   <name>
    <surname>Young</surname>
    <given-names>G</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Emicizumab Prophylaxis in Hemophilia A with Inhibitors</article-title>
  <source>N Engl J Med</source>
  <year>2017</year>
  <volume>377</volume>
  <fpage>809</fpage>
  <lpage>818</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1703068</pub-id>
  <?supplied-pmid 28691557?>
  <pub-id pub-id-type="pmid">28691557</pub-id>
 </element-citation>
</ref>
